Hi mooers!
Welcome back to our monthly Moo Leaderboards!
March has wrapped up, and we're grateful to every mooer who shared insights and supported fellow investors—your contributions have made this community truly special.
Now, let's honor the top contributors for March 2026! Check out their profiles in the Moo Community and follow them for more great content.
Top 10 influential mooers of March
Congratulations to @Trytosaveabit, @DrJaguar8, @Michael_11, ...

Shopify’s down 16% YTD; SoFi’s off 9% post-Q4 earnings. Both face valuation questions, but who’s got the edge?
$Shopify (SHOP.US)$ :
– 📈 32% revenue growth (Q3 2025), profitable over 12 months.
– 🌍 E-commerce secular trend = long-term winner.
– ⚖️ PEG ratio 1.1 (undervalued territory).
$SoFi Technologies (SOFI.US)$ :
– 💸 Q4 revenues hit $1B+, adjusted net income +184% YoY.
– 👥 13.7M members (+35%), fee-based revenues +53%.
– 🔄 Management calls i...

$Medline (MDLN.US)$ just received the meseage.

$Medline (MDLN.US)$  YEAHHH 3 SHARES BABYYY WOOOO 🔥🔥

$Medline (MDLN.US)$ i requested $18,500 worth and i got 14 shares. waste of time freezing up my money for a week

$Medline (MDLN.US)$ 47 shares

$Medline (MDLN.US)$ This IPO was priced at $29 per share, raising over $6.2 billion, making it one of the largest standalone IPOs in 2025, with strong institutional subscription interest. Typically, IPOs experience significant volatility on their first day. Short-term: There may be an opening premium due to 'subscription premium realization,' but there could also be selling pressure at key resistance levels. High uncertainty makes trading volume critical. Mid-term: Medline is a global leader in medical supplies, with stable long-term cash flow, a large market share, and insensitivity to economic cycles, giving it stronger fundamentals than most IPOs. If the opening exhibits strong volume and stabilizes above key price levels, there could be upside potential in the short term; however, if volume is weak or prices retreat, the first-day high should be viewed cautiously.